Mechanisms and therapeutic potential of multiple forms of programmed cell death in renal fibrosis
- 7 June 2025
- journal article
- review article
- Published by Elsevier in Cellular Signalling
- Vol. 134, 111926
Abstract
No abstract availableKeywords
Funding Information
- Anhui University of Chinese Medicine (2023CXMMTCM018)
- Natural Science Foundation of Anhui Province (2308085MH292, 202407290785)
- National Natural Science Foundation of China (82274307)
This publication has 193 references indexed in Scilit:
- VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO‐1 Signaling Pathway in Diabetic NephropathyAdvanced Science, 2023
- Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathwayCell Biology and Toxicology, 2023
- Disulfiram inhibits inflammation and fibrosis in a rat unilateral ureteral obstruction model by inhibiting gasdermin D cleavage and pyroptosisInflammation Research, 2021
- The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticlesBioengineering & Translational Medicine, 2020
- Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation2019
- SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusionApoptosis, 2017
- Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and AnemiaJAMA Internal Medicine, 2014
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- p53 and apoptosisSeminars in Cancer Biology, 1998
- Apoptosis and cell desquamation in repair process of ischemic tubular necrosisVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993